267 related articles for article (PubMed ID: 10917543)
1. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions.
Andersson S; Alemi M; Rylander E; Strand A; Larsson B; Sällström J; Wilander E
Br J Cancer; 2000 Aug; 83(3):307-10. PubMed ID: 10917543
[TBL] [Abstract][Full Text] [Related]
2. Rapid test for identification of a human papillomavirus 16 E6 L83V variant.
Alemi M; Andersson S; Sällström J; Wilander E
Diagn Mol Pathol; 1999 Jun; 8(2):97-100. PubMed ID: 10475384
[TBL] [Abstract][Full Text] [Related]
3. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population.
Matsumoto K; Yoshikawa H; Nakagawa S; Tang X; Yasugi T; Kawana K; Sekiya S; Hirai Y; Kukimoto I; Kanda T; Taketani Y
Cancer Lett; 2000 Aug; 156(2):159-65. PubMed ID: 10880765
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
[TBL] [Abstract][Full Text] [Related]
5. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
[TBL] [Abstract][Full Text] [Related]
6. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.
Nindl I; Rindfleisch K; Lotz B; Schneider A; Dürst M
Int J Cancer; 1999 Jul; 82(2):203-7. PubMed ID: 10389753
[TBL] [Abstract][Full Text] [Related]
7. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
[TBL] [Abstract][Full Text] [Related]
8. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
Quint KD; de Koning MN; van Doorn LJ; Quint WG; Pirog EC
Gynecol Oncol; 2010 May; 117(2):297-301. PubMed ID: 20207397
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer.
Matsumoto K; Yasugi T; Nakagawa S; Okubo M; Hirata R; Maeda H; Yoshikawa H; Taketani Y
Int J Cancer; 2003 Oct; 106(6):919-22. PubMed ID: 12918070
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 E6 gene variations in Chinese population.
Cai HB; Chen CC; Ding XH
Eur J Surg Oncol; 2010 Feb; 36(2):160-3. PubMed ID: 19699050
[TBL] [Abstract][Full Text] [Related]
11. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
Jiang B; Xue M
Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes.
Wu Z; Li TY; Jiang M; Yu L; Zhao J; Wang H; Zhang X; Chen W; Qiao Y
Cancer Prev Res (Phila); 2019 Feb; 12(2):95-102. PubMed ID: 30606718
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
[TBL] [Abstract][Full Text] [Related]
14. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
15. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions.
Chaiwongkot A; Vinokurova S; Pientong C; Ekalaksananan T; Kongyingyoes B; Kleebkaow P; Chumworathayi B; Patarapadungkit N; Reuschenbach M; von Knebel Doeberitz M
Int J Cancer; 2013 May; 132(9):2087-94. PubMed ID: 23065631
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of HPV16 E6*I transcripts in high-grade cervical cytology and histology (CIN II+) detected by rapid real-time RT-PCR amplification.
Kösel S; Burggraf S; Engelhardt W; Olgemöller B
Cytopathology; 2007 Oct; 18(5):290-9. PubMed ID: 17662070
[TBL] [Abstract][Full Text] [Related]
17. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
18. p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
Limpaiboon T; Pooart J; Bhattarakosol P; Niruthisard S; Chantratita W; Lulitanond V
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):66-71. PubMed ID: 11023067
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype.
Zehbe I; Wilander E; Delius H; Tommasino M
Cancer Res; 1998 Feb; 58(4):829-33. PubMed ID: 9485042
[TBL] [Abstract][Full Text] [Related]
20. Delta-Like Ligand-Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis.
Khelil M; Griffin H; Bleeker MCG; Steenbergen RDM; Zheng K; Saunders-Wood T; Samuels S; Rotman J; Vos W; van den Akker BE; de Menezes RX; Kenter GG; Doorbar J; Jordanova ES
Cancer Res; 2021 Apr; 81(7):1909-1921. PubMed ID: 33500246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
